Asklepios Kliniken

Standard-of-care ciltacabtagene autoleucel in earlier versus later lines of therapy for relapsed or refractory multiple myeloma: a nationwide registry analysis (2026) Gagelmann N, Einsele H, Flossdorf S, Smaili S, Metzeler K, Scheid C, Bullinger L, et al. Journal article Targeting the transcription factor GATA3 by the DNAzyme formulation SB012 in patients with moderately-to-severely active ulcerative colitis: a multicenter, randomized, placebo-controlled, phase 2a induction trial (2026) Atreya R, Kühbacher T, Vieth M, Jefremow A, Hirschmann S, Waldner M, Fischer S, et al. Journal article Statement by the Uterus Commission of the Arbeitsgemeinschaft Gynäkologische Onkologie [German Gynecological Oncology Group] (AGO) on the ESGO-ESTRO-ESP Guideline 2025 (2026) Ataseven B, Battista M, Beckmann M, Brucker S, Denschlag D, Eichbaum M, Fehm T, et al. Journal article Multidisciplinary guidelines on renal replacement therapy in intensive care medicine (2026) Meersch-Dini M, Abu-Tair M, Bayer M, Brinkmann A, Bellmann R, Brunkhorst F, Custodis F, et al. Journal article, Review article Unterschätzt, unterbehandelt und unbequem: Die PAVK braucht einen Gefäßgipfel! (2026) Behrendt CA, Adili F, Rother U Journal article What is the best path towards allogeneic transplantation in MDS and AML? A survey among German-spreaking centers for allogeneic hematopoietic stem cell transplantation. (2026) Krause S, Bethge W, Bug G, Elmaagacli A, Jost E, Klein SA, Kobbe G, et al. Journal article Correction to: DEGRO statement on the KEYNOTE-689 trial: Perioperative immunotherapy in combination with adjuvant (chemo-)radiotherapy for resectable locally advanced head and neck cancers (Strahlentherapie und Onkologie, (2026), 202, 4, (359-361), 10.1007/s00066-026-02511-6) (2026) Schnellhardt S, Böke S, Tribius S, Krause M, Haderlein M, Rühle A, Süß C, et al. Journal article, Erratum DEGRO statement on the KEYNOTE-689 trial: Perioperative immunotherapy in combination with adjuvant (chemo-)radiotherapy for resectable locally advanced head and neck cancers (2026) Schnellhardt S, Böke S, Tribius S, Krause M, Haderlein M, Rühle A, Süß C, et al. Journal article Real-world experience with first-line CPX-351 treatment in patients with acute myeloid leukemia – long-term follow-up with focus on younger patients (2025) Rautenberg C, Middeke JM, Röllig C, Stelljes M, Gaidzik V, Kriege O, Verbeek M, et al. Journal article Derivation and validation of a non-invasive optoacoustic imaging biomarker for detection of patients with intermittent claudication (2025) Caranovic M, Kempf J, Li Y, Regensburger A, Günther J, Träger AP, Lang W, et al. Journal article